Literature DB >> 28664294

Rare causes of early-onset dystonia-parkinsonism with cognitive impairment: a de novo PSEN-1 mutation.

Miryam Carecchio1,2,3, Marina Picillo4, Lorella Valletta1, Antonio E Elia5, Tobias B Haack6,7,8, Autilia Cozzolino4, Annalisa Vitale4, Barbara Garavaglia1, Arcangela Iuso6,7, Caterina F Bagella5, Sabina Pappatà9, Paolo Barone4, Holger Prokisch6,7, Luigi Romito5, Valeria Tiranti10.   

Abstract

Mutations in PSEN1 are responsible for familial Alzheimer's disease (FAD) inherited as autosomal dominant trait, but also de novo mutations have been rarely reported in sporadic early-onset dementia cases. Parkinsonism in FAD has been mainly described in advanced disease stages. We characterized a patient presenting with early-onset dystonia-parkinsonism later complicated by dementia and myoclonus. Brain MRI showed signs of iron accumulation in the basal ganglia mimicking neurodegeneration with brain iron accumulation (NBIA) as well as fronto-temporal atrophy. Whole exome sequencing revealed a novel PSEN1 mutation and segregation within the family demonstrated the mutation arose de novo.We suggest considering PSEN1 mutations in cases of dystonia-parkinsonism with positive DAT-Scan, later complicated by progressive cognitive decline and cortical myoclonus even without a dominant family history.

Entities:  

Keywords:  Dystonia; NBIA; NGS; PSEN1; Parkinsonism

Mesh:

Substances:

Year:  2017        PMID: 28664294     DOI: 10.1007/s10048-017-0518-4

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  11 in total

1.  New V272A presenilin 1 mutation with very early onset subcortical dementia and parkinsonism.

Authors:  A Jimenez-Escrig; A Rabano; C Guerrero; J Simon; M S Barquero; I Güell; R C Ginestal; T Montero; L Orensanz
Journal:  Eur J Neurol       Date:  2004-10       Impact factor: 6.089

2.  Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life.

Authors:  B Joy Snider; Joanne Norton; Mary A Coats; Sumi Chakraverty; Craig E Hou; Ramiro Jervis; Corinne L Lendon; Alison M Goate; Daniel W McKeel; John C Morris
Journal:  Arch Neurol       Date:  2005-12

3.  Frontotemporal dementia as the presenting phenotype of p.A53T mutation carriers in the alpha-synuclein gene.

Authors:  Anastasia Bougea; Christos Koros; Maria Stamelou; Athina Simitsi; Nikolaos Papagiannakis; Roubina Antonelou; Dimitra Papadimitriou; Marianthi Breza; Konstantinos Tasios; Stella Fragkiadaki; Xenia Geronicola Trapali; Mara Bourbouli; Georgios Koutsis; Sokratis G Papageorgiou; Elisabeth Kapaki; George P Paraskevas; Leonidas Stefanis
Journal:  Parkinsonism Relat Disord       Date:  2016-12-06       Impact factor: 4.891

4.  Very early-onset sporadic Alzheimer's disease with a de novo mutation in the PSEN1 gene.

Authors:  Fan Lou; Xiaoguang Luo; Ming Li; Yan Ren; Zhiyi He
Journal:  Neurobiol Aging       Date:  2017-01-06       Impact factor: 4.673

5.  Novel presenilin 1 mutations associated with early onset of dementia in a family with both early-onset and late-onset Alzheimer disease.

Authors:  G Devi; A Fotiou; D Jyrinji; B Tycko; S DeArmand; E Rogaeva; Y Q Song; H Medieros; Y Liang; A Orlacchio; J Williamson; P St George-Hyslop; R Mayeux
Journal:  Arch Neurol       Date:  2000-10

6.  De novo presenilin 1 mutations are rare in clinically sporadic, early onset Alzheimer's disease cases. French Alzheimer's Disease Study Group.

Authors:  C Dumanchin; A Brice; D Campion; D Hannequin; C Martin; V Moreau; Y Agid; M Martinez; F Clerget-Darpoux; T Frebourg
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

7.  Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease.

Authors:  J Y Chen; Y Stern; M Sano; R Mayeux
Journal:  Arch Neurol       Date:  1991-11

8.  A novel mutation (G217D) in the Presenilin 1 gene ( PSEN1) in a Japanese family: presenile dementia and parkinsonism are associated with cotton wool plaques in the cortex and striatum.

Authors:  Masaki Takao; Bernardino Ghetti; Isao Hayakawa; Eiji Ikeda; Yasuo Fukuuchi; Leticia Miravalle; Pedro Piccardo; Jill R Murrell; Bradley S Glazier; Atsuo Koto
Journal:  Acta Neuropathol       Date:  2002-04-19       Impact factor: 17.088

9.  Early-onset Alzheimer's disease with a de novo mutation in the presenilin 1 gene.

Authors:  M P Golan; M Styczyńska; K Jóźwiak; J Walecki; A Maruszak; J Pniewski; R Lugiewicz; S Filipek; C Zekanowski; M Barcikowska
Journal:  Exp Neurol       Date:  2007-09-05       Impact factor: 5.330

10.  The natural history of Alzheimer disease: a longitudinal presymptomatic and symptomatic study of a familial cohort.

Authors:  Alison K Godbolt; Lisa Cipolotti; Hilary Watt; Nick C Fox; John C Janssen; Martin N Rossor
Journal:  Arch Neurol       Date:  2004-11
View more
  5 in total

Review 1.  Genetics of Movement Disorders and the Practicing Clinician; Who and What to Test for?

Authors:  Alessio Di Fonzo; Edoardo Monfrini; Roberto Erro
Journal:  Curr Neurol Neurosci Rep       Date:  2018-05-23       Impact factor: 5.081

2.  A heterozygous de novo PSEN1 mutation in a patient with early-onset parkinsonism.

Authors:  Yueting Chen; Peng Liu; Fei Xie; Bo Wang; Zhiru Lin; Wei Luo
Journal:  Neurol Sci       Date:  2021-11-29       Impact factor: 3.307

Review 3.  The role of de novo mutations in adult-onset neurodegenerative disorders.

Authors:  Gaël Nicolas; Joris A Veltman
Journal:  Acta Neuropathol       Date:  2018-11-26       Impact factor: 17.088

4.  A pathogenic PSEN1 Trp165Cys mutation associated with early-onset Alzheimer's disease.

Authors:  Vo Van Giau; Jung-Min Pyun; Jeewon Suh; Eva Bagyinszky; Seong Soo A An; Sang Yun Kim
Journal:  BMC Neurol       Date:  2019-08-07       Impact factor: 2.474

5.  Pleiotropic Effects of Variants in Dementia Genes in Parkinson Disease.

Authors:  Laura Ibanez; Umber Dube; Albert A Davis; Maria V Fernandez; John Budde; Breanna Cooper; Monica Diez-Fairen; Sara Ortega-Cubero; Pau Pastor; Joel S Perlmutter; Carlos Cruchaga; Bruno A Benitez
Journal:  Front Neurosci       Date:  2018-04-10       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.